Literature DB >> 28481662

The Correlation Between Body Fat, Visceral Fat, and Nonalcoholic Fatty Liver Disease.

Yun-Huei Ko1, Te-Chih Wong2, Ying-Ying Hsu1, Kuan-Liang Kuo3, Shwu Huey Yang4,5.   

Abstract

BACKGROUND: This study investigated the correlation between body fat, visceral fat, and the presence of nonalcoholic fatty liver disease (NAFLD).
METHODS: In this cross-sectional study, participants were required to be 20 years or older, and free of liver disease (comprising either the hepatitis C virus antibody or hepatitis B surface antigen), cirrhosis, and malignant or biliary diseases. A total of 2759 participants were collected for this study. Demographic and biochemical data were collected by chart review. For estimating body fat and visceral fat, anthropometric and bioelectrical impedance analyses were conducted, whereas fatty livers were diagnosed through an abdominal ultrasound.
RESULTS: The waist circumference (WC), body mass index (BMI), body fat, visceral fat, and metabolic syndrome (MS) were associated with NAFLD. A larger WC, higher BMI, higher levels of body and visceral fat, and the MS significantly correlated with the presence of a fatty liver. Additionally, the receiver operating characteristic suggested that the visceral fat cutoff point was 70.5 cm2 (Youden's index = 0.4352).
CONCLUSIONS: Visceral fat is a strong predictor of NAFLD.

Entities:  

Keywords:  bioelectrical impedance analysis; body fat; nonalcoholic fatty liver; visceral fat

Mesh:

Year:  2017        PMID: 28481662     DOI: 10.1089/met.2017.0001

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  16 in total

1.  Associations of Visceral, Subcutaneous, Epicardial, and Liver Fat with Metabolic Disorders up to 14 Years After Weight Loss Surgery.

Authors:  Steven C Hunt; Lance E Davidson; Ted D Adams; Lauren Ranson; Rodrick D McKinlay; Steven C Simper; Sheldon E Litwin
Journal:  Metab Syndr Relat Disord       Date:  2020-11-02       Impact factor: 1.894

Review 2.  The role of NAFLD in cardiometabolic disease: an update.

Authors:  Sarah Faasse; Hayley Braun; Miriam Vos
Journal:  F1000Res       Date:  2018-02-09

3.  Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): A United Kingdom population-based cohort study using the health improvement network (THIN).

Authors:  A Vusirikala; T Thomas; N Bhala; A A Tahrani; G N Thomas; K Nirantharakumar
Journal:  BMC Endocr Disord       Date:  2020-06-30       Impact factor: 2.763

4.  Hypothalamic Gliosis by MRI and Visceral Fat Mass Negatively Correlate with Plasma Testosterone Concentrations in Healthy Men.

Authors:  Kathryn E Berkseth; Katya B Rubinow; Susan J Melhorn; Mary F Webb; Mary Rosalynn B De Leon; Brett T Marck; Alvin M Matsumoto; John K Amory; Stephanie T Page; Ellen A Schur
Journal:  Obesity (Silver Spring)       Date:  2018-12       Impact factor: 5.002

5.  Metabolic Characteristics of a Novel Ultrasound Quantitative Diagnostic Index for Nonalcoholic Fatty Liver Disease.

Authors:  Yin-Yin Liao; Chih-Kuang Yeh; Kuo-Chin Huang; Po-Hsiang Tsui; Kuen-Cheh Yang
Journal:  Sci Rep       Date:  2019-05-28       Impact factor: 4.379

Review 6.  Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease.

Authors:  Hamza El Hadi; Angelo Di Vincenzo; Roberto Vettor; Marco Rossato
Journal:  Int J Mol Sci       Date:  2019-05-06       Impact factor: 5.923

7.  The Effect of a Family-Based Lifestyle Education Program on Dietary Habits, Hepatic Fat and Adiposity Markers in 8-12-Year-Old Children with Overweight/Obesity.

Authors:  Lide Arenaza; María Medrano; Maddi Oses; Maria Amasene; Ignacio Díez; Beatriz Rodríguez-Vigil; Idoia Labayen
Journal:  Nutrients       Date:  2020-05-16       Impact factor: 5.717

8.  Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.

Authors:  Louise Johanna Maria Alferink; Katerina Trajanoska; Nicole Stephanie Erler; Josje Dorothea Schoufour; Robert Jacobus de Knegt; M Arfan Ikram; Harry Leonardus Antonius Janssen; Oscar H Franco; Herold J Metselaar; Fernando Rivadeneira; Sarwa Darwish Murad
Journal:  J Bone Miner Res       Date:  2019-05-10       Impact factor: 6.741

9.  Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease.

Authors:  Marta Hernández-Conde; Elba Llop; Carlos Fernández Carrillo; Beatriz Tormo; Javier Abad; Luis Rodriguez; Christie Perelló; Marta López Gomez; José Luis Martínez-Porras; Natalia Fernández Puga; Maria Trapero-Marugan; Enrique Fraga; Carlos Ferre Aracil; José Luis Calleja Panero
Journal:  World J Gastroenterol       Date:  2020-11-14       Impact factor: 5.742

Review 10.  Artificial sweeteners are related to non-alcoholic fatty liver disease: Microbiota dysbiosis as a novel potential mechanism.

Authors:  Hadi Emamat; Hamid Ghalandari; Hadith Tangestani; Afsoun Abdollahi; Azita Hekmatdoost
Journal:  EXCLI J       Date:  2020-05-12       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.